Turner's study looked only for exaggeration of antidepressants' benefits, not at their often terrible side effects. But selective publication can also keep the public in the dark about serious harm that drugs can do.
studies that the FDA judged as positive were approximately 12 times as likely to be published in a way that agreed with the FDA as were studies with nonpositive results
pharmaceutical companies tend to publish research that's favorable to their products and leave unfavorable results tucked away in their files.
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.